ABSTRACT
Background Pharmacist Interventions (PIs) are actions proposed by pharmacists during the prescription review process to address non-optimal drug use. PIs must be triggered by drug-related problems (DRP) but can also be recommendations for better prescribing and administration practices. PIs are produced daily text documents and messages forwarded to prescribers. Although they could be used retrospectively to build on safeguards for preventing DRP, the reuse of the PIs data is under-exploited.
Objective The objective of this work is to train a deep learning algorithm able to automatically categorize PIs to value this large amount of data.
Materials and Methods The study was conducted at the University Hospital of Strasbourg. PIs data was collected over the year 2017. Data from the first six months of 2017 was labelled by two pharmacists, who manually assigned one of the 29 possible classes from the French Society of Clinical Pharmacy classification. A deep neural network classifier was trained to learn to automatically predict the class of PIs from the processed text data.
Results 27,699 labelled PIs were used to train and evaluate a classifier. The accuracy of the prediction calculated on the validation dataset was 78.0%. We predicted classes for the PIs collected in the second half of 2017. Of the 4,460 predictions checked manually, 67 required corrections. These verified data was concatenated with the original dataset to create an extended dataset to re-train the neural network. The accuracy achieved was 81.0 %, showing that the prediction process can be further improved as the amount of data increases.
Conclusions PIs classification is beneficial for assessing and improving pharmaceutical care practice. Here we report a high-performance automatic classification of PIs based on deep learning that could find a place in highlighting the clinical relevance of the drug prescription review performed daily by hospital pharmacists.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Comite d'ethique des Facultes de Medecine, d'Odontologie, de Pharmacie, des Ecoles d'Infirmieres, de Kinesitherapie, de Maieutique et des Hopitaux gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Updated version of the article - dec 2022
Data Availability
All data produced in the present study are available upon reasonable request to the authors
